• Latest Posts

Five recent advancements in ovarian cancer research over the past year

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Exeliom Biosciences closes €24M financing for lead candidate 

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

ADVERTISEMENT
In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

Researchers explain how some lung tumors avoid immunotherapy

Vaccitech announces positive topline data for chronic hepatitis study

ADVERTISEMENT